EUVIMEDEUVIMED entdecken
Crossref

IMMEDIATE LYMPHATIC RECONSTRUCTION DURING AXILLARY DISSECTION FOR LYMPHEDEMA PREVENTION AFTER BREAST CANCER TREATMENT

Marisa Peçanha De Barros, Gabriel Künzle Ribeiro Magalhães, Julia Souto Faria Navarro, Thiago Rodrigues Ferreira, Nubia Machado Vieira Dos Santos, Guilherme Yoshiharu Mabuchi, Ana Luiza Moyzés Pereira, Ana Júlia Peron, Giancarlo Calselin Monnazzi

LUMEN ET VIRTUS · 17.08.2026 · 17 (63) · e14094

DOI: 10.56238/levv17n63-039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift LUMEN ET VIRTUS, online erschienen am 17.08.2026. Verfasst von Marisa Peçanha De Barros und 8 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Breast cancer-related lymphedema (BCRL) is a chronic complication of axillary lymph node dissection (ALND) that can impair upper-limb function, psychosocial well-being, and quality of life. Immediate lymphatic reconstruction (ILR) uses microsurgical lymphaticovenous bypass (LVB) during ALND to restore lymphatic drainage before clinical lymphedema develops.

Objective

To evaluate the effectiveness, safety, technical feasibility, and methodological certainty of ILR for preventing BCRL after breast cancer treatment.

Methods

A systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses principles. PubMed, Scopus, Web of Science, the Cochrane Library, LILACS, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform were searched for recent human studies. Randomized and nonrandomized comparative studies, prospective cohorts, and clinically informative case series were eligible. Risk of bias was assessed with RoB 2 and ROBINS-I, and certainty of evidence was evaluated using GRADE. Results and Discussion: Twenty studies were included. Most observational studies reported lower BCRL incidence after technically successful ILR, commonly between 4% and 12%, compared with approximately 20%–50% in contemporaneous or historical ALND controls. Preliminary randomized evidence also favored ILR, but another prospective pragmatic study found no significant adjusted difference. Technical success depended on lymphatic visualization, recipient-vein availability, microsurgical expertise, body mass index, and operative anatomy. Oncologic recurrence patterns did not indicate an evident axillary safety signal, although follow-up was insufficient for definitive oncologic conclusions. Heterogeneous diagnostic thresholds, variable surveillance duration, selection bias, incomplete blinding, and attrition reduced confidence in pooled estimates.

Conclusion

ILR is a promising preventive microsurgical strategy that may substantially reduce BCRL after ALND. Its use is best supported in experienced multidisciplinary centers with standardized surveillance, while adequately powered multicenter randomized trials establish long-term effectiveness, oncologic safety, cost-effectiveness, and patient-selection criteria.

Zitieren

APA

Barros, M. P. D., Magalhães, G. K. R., Navarro, J. S. F., Ferreira, T. R., Santos, N. M. V. D., Mabuchi, G. Y., Pereira, A. L. M., Peron, A. J., & Monnazzi, G. C. (2026). IMMEDIATE LYMPHATIC RECONSTRUCTION DURING AXILLARY DISSECTION FOR LYMPHEDEMA PREVENTION AFTER BREAST CANCER TREATMENT. LUMEN ET VIRTUS, 17(63), e14094. https://doi.org/10.56238/levv17n63-039

Vancouver

Barros MPD, Magalhães GKR, Navarro JSF, Ferreira TR, Santos NMVD, Mabuchi GY, et al. IMMEDIATE LYMPHATIC RECONSTRUCTION DURING AXILLARY DISSECTION FOR LYMPHEDEMA PREVENTION AFTER BREAST CANCER TREATMENT. LUMEN ET VIRTUS. 2026;17(63):e14094. doi:10.56238/levv17n63-039

BibTeX
@article{Barros2026,
  author = {Barros, Marisa Peçanha De and Magalhães, Gabriel Künzle Ribeiro and Navarro, Julia Souto Faria and Ferreira, Thiago Rodrigues and Santos, Nubia Machado Vieira Dos and Mabuchi, Guilherme Yoshiharu and Pereira, Ana Luiza Moyzés and Peron, Ana Júlia and Monnazzi, Giancarlo Calselin},
  title = {IMMEDIATE LYMPHATIC RECONSTRUCTION DURING AXILLARY DISSECTION FOR LYMPHEDEMA PREVENTION AFTER BREAST CANCER TREATMENT},
  journal = {LUMEN ET VIRTUS},
  year = {2026},
  volume = {17},
  number = {63},
  pages = {e14094},
  doi = {10.56238/levv17n63-039}
}
Kostenlos starten →